Latest news
Certain Common Shares of Cybin Inc. are subject to a Lock-Up Agreement Ending on 9-AUG-2026. - marketscreener.commarketscreener.com · Sun, 09 Aug 2026 00:38:55 GMTTop Cybin (HELP) Competitors 2026 - MarketBeatMarketBeat · Sat, 08 Aug 2026 20:02:28 GMTCybin (HELP) Names New CEO, Is The Stock Still Cheap? - Yahoo! Finance CanadaYahoo! Finance Canada · Sat, 08 Aug 2026 18:10:30 GMTCybin D/B/A Helus Pharma (HELP) stock price, news, quote and history - Yahoo Finance UKYahoo Finance UK · Fri, 07 Aug 2026 23:15:50 GMTCybin Inc (CN:HELP) Rallies 4.62%: rebranded psychedelic-medicine developer is trading briskly after a new CEO and an ahead-of-schedule Phase 3 enrollment, - kalkine.cakalkine.ca · Fri, 07 Aug 2026 10:36:00 GMTCybin (HELP) Is Up 33.1% After Hiring Helus Veteran Michael Halstead As CEO – Has The Bull Case Changed? - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 14:18:09 GMTCybin (Helus Pharma, HELP) Leaps 14% Ahead of Pivotal Depression Trial Data - kalkine.cakalkine.ca · Thu, 06 Aug 2026 12:56:00 GMTCould Helus Pharma’s New CEO Reframe Cybin’s (HELP) Path From Clinical Trials To Commercial Scale? - simplywall.stsimplywall.st · Thu, 06 Aug 2026 06:49:30 GMT